Contribution of hypercapnia and hypoxia to the vascular response to ischaemia.
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001783:Blood Flow Velocity; D001784:Blood Gas Analysis; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000378:metabolism / Q000494:pharmacology; D002986:Clinical Trials as Topic; D005542:Forearm / Q000098:blood supply; D006801:Humans; D006935:Hypercapnia / Q000503:physiopathology*; D000860:Hypoxia / Q000503:physiopathology*; D007511:Ischemia / Q000503:physiopathology*; D008722:Methods; D010100:Oxygen / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010991:Plethysmography; D011433:Propranolol / Q000494:pharmacology; D013997:Time Factors; D014655:Vascular Resistance; D014666:Vasomotor System / Q000502:physiology*; D014690:Venous Pressure
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010643:Phenoxybenzamine; D002245:Carbon Dioxide; D011433:Propranolol; D010100:Oxygen